GARAGIOLA, ISABELLA MARIA
 Distribuzione geografica
Continente #
EU - Europa 4.530
NA - Nord America 2.927
AS - Asia 1.694
SA - Sud America 98
OC - Oceania 21
AF - Africa 20
Continente sconosciuto - Info sul continente non disponibili 15
Totale 9.305
Nazione #
US - Stati Uniti d'America 2.797
GB - Regno Unito 1.859
CN - Cina 788
DE - Germania 678
SE - Svezia 563
IT - Italia 472
SG - Singapore 427
RU - Federazione Russa 244
IN - India 129
IE - Irlanda 121
UA - Ucraina 112
CA - Canada 102
FR - Francia 101
TR - Turchia 96
NL - Olanda 77
FI - Finlandia 76
KR - Corea 76
EU - Europa 75
DK - Danimarca 58
BR - Brasile 57
ID - Indonesia 49
JP - Giappone 36
ES - Italia 34
HK - Hong Kong 32
CO - Colombia 29
NO - Norvegia 22
MX - Messico 20
AU - Australia 19
CH - Svizzera 19
BE - Belgio 17
IR - Iran 16
PL - Polonia 14
RO - Romania 13
AT - Austria 11
EG - Egitto 11
GR - Grecia 11
VN - Vietnam 8
PT - Portogallo 7
CZ - Repubblica Ceca 5
PH - Filippine 5
MY - Malesia 4
AE - Emirati Arabi Uniti 3
BD - Bangladesh 3
MD - Moldavia 3
TH - Thailandia 3
TW - Taiwan 3
UZ - Uzbekistan 3
VE - Venezuela 3
ZA - Sudafrica 3
AM - Armenia 2
AR - Argentina 2
BG - Bulgaria 2
BQ - ???statistics.table.value.countryCode.BQ??? 2
BZ - Belize 2
CR - Costa Rica 2
IQ - Iraq 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PE - Perù 2
PK - Pakistan 2
PY - Paraguay 2
QA - Qatar 2
RS - Serbia 2
SC - Seychelles 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
DO - Repubblica Dominicana 1
GE - Georgia 1
HR - Croazia 1
IS - Islanda 1
JM - Giamaica 1
LV - Lettonia 1
MA - Marocco 1
ME - Montenegro 1
MK - Macedonia 1
MM - Myanmar 1
NI - Nicaragua 1
OM - Oman 1
PR - Porto Rico 1
SA - Arabia Saudita 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
Totale 9.368
Città #
Southend 1.678
Singapore 333
Chandler 293
Hanover 275
Seattle 199
Milan 198
Houston 191
Princeton 159
Wilmington 151
Ashburn 137
Fairfield 133
Beijing 132
Dublin 121
Dearborn 104
Frankfurt am Main 101
Jacksonville 82
Woodbridge 81
Ann Arbor 77
Nanjing 77
Redmond 70
Ottawa 69
Mountain View 61
Santa Clara 58
Cambridge 57
Des Moines 53
Bengaluru 49
Sakarya 40
Jakarta 38
Redwood City 38
Shenyang 36
Saint Petersburg 33
Boardman 32
Jinan 32
Phoenix 31
Bogotá 29
Serra 29
Changsha 28
Hangzhou 27
Shanghai 27
Andover 26
Guangzhou 25
Somerville 24
Helsinki 23
Toronto 22
Fuzhou 21
Munich 21
Nanchang 21
London 20
Margão 20
New York 20
Pisa 20
Bitonto 19
Hebei 19
Kunming 19
Roxbury 19
Eitensheim 18
Tianjin 18
Centro 17
Hong Kong 17
Grafing 16
Turin 16
Medford 15
Silver Spring 14
Madrid 13
Wuhan 13
Zhengzhou 13
Brussels 12
San Diego 12
Berlin 11
Duncan 11
Athens 10
Jiaxing 10
Nuremberg 10
Rome 10
Los Angeles 9
Quanzhou 9
Taiyuan 9
Zurich 9
Fremont 8
São Paulo 8
Taizhou 8
Yubileyny 8
Atlanta 7
Bangalore 7
Copenhagen 7
Hefei 7
Kent 7
Ningbo 7
Tokyo 7
Washington 7
Amsterdam 6
Barcelona 6
Chicago 6
Haikou 6
Lanzhou 6
Leiden 6
Birmingham 5
Cairo 5
Columbus 5
Cupertino 5
Totale 6.134
Nome #
A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A 542
Timing and severity of inhibitor development in recombinant versus plasma-derived factor VIII concentrates: a SIPPET analysis 463
Whole-exome sequencing to identify genetic risk variants underlying inhibitor development in severe hemophilia A patients 398
Thrombotic Thrombocytopenic Purpura (TTP) Database 229
The first deletion mutation in the TSP1-6 repeat domain of ADAMTS13 in a family with inherited thrombotic thrombocytopenic purpura 196
Prediction of Factor VIII inhibitor development in the SIPPET cohort by mutational analysis and Factor VIII antigen measurement 195
International Rare Bleeding Disorders Database 191
ADAMTS13 mutations and polymorphisms in congenital thrombotic thrombocytopenic purpura 184
Genetics of rare bleeding disorders 179
Non-invasive tool for foetal sex determination in early gestational age 178
Cytogenetic abnormalities and microsatellite instability in endometrial adenocarcinoma 173
Genetic diagnosis of haemophilia and other inherited bleeding disorders 162
Highly sensitive chemiluminescent method for the detection of cell contamination 162
Database on rare bleeding disorder (RBDS) : phenotype and genotype analysis on 400 affected patients 161
Role of von Willebrand factor in the haemostasis 158
A rare inherited coagulation disorder : combined homozygous factor VII and factor X deficiency 155
A novel CD46 mutation in a patient with microangiopathy clinically resembling thrombotic thrombocytopenic purpura and normal ADAMTS13 activity 153
A recurrent F8 mutation (c.6046C>T) causing hemophilia A in 8% of northern Italian patients : evidence for a founder effect 148
Trisomic zygote rescue revealed by DNA polymorphism analysis in confined placental mosaicism 147
Absence of detectable maternal DNA and identification of proviral HIV in the cord blood of two infants who became HIV-infected 147
Highly sensitive chemiluminescent method for the detection of maternal cell contamination in human cord blood stored for allotransplantation : the experience of the Milano cord blood bank 146
The First Deletion Mutation in the TSP1-6 Repeat Domain of ADAMTS13 Leads to a Secretion Defect 143
Nonsense-mediated mRNA decay in the ADAMTS13 gene caused by a 29-nucleotide deletion 142
International Registry of rare bleeding disorders (RBD) 140
Detection of maternal DNA in cord blood at birth after elective caesarean section or vaginal delivery 140
Reproductive care in human immunodeficiency virus serodiscordant couples with haemophilia 140
Mutational Repertoire in the SIPPET Cohort and Prediction of FVIII Inhibitor Risk 138
Platelet ADAMTS13 and in vitro expression study of a patient affected by congenital TTP 136
The Influence of F8 Mutation and Thrombophilic Genetic Markers on Bleeding Phenotype of Patients Affected with Severe Hemophilia A in the SIPPET Cohort 136
Losses of heterozygosity in endometrial adenocarcinomas : positive correlations with histopathological parameters 135
The first deletion mutation in the TSP1-6 repeat domain of ADAMTS13 leads to a secretion defect 134
Recurrent mutations identified on LMAN1 and coagulation factors VII, X, XIII genes 133
ADAMTS-13 Binds Platelets in a Specific, Divalent Cation and Activation Dependent Manner 132
Losses of heterozygosity in oral and oropharyngeal epithelial carcinomas 131
Characterization of four microsatellites in an Italian population and their application to paternity testing 129
Dalla diagnosi di portatrice di emofilia alla diagnosi prenatale 126
Role of the 2 adenine (g.11293_11294insAA) insertion polymorphism in the 3' untranslated region of the factor VII (FVII) gene : molecular characterization of a patient with severe FVII deficiency 124
Mutations in the MCFD2 gene and a novel mutation in the LMAN1 gene in Indian families with combined deficiency of factor V and VIII 122
Psychological and cognitive factors involved in decision‐making process of haemophilia carriers in reproductive choices 120
Severe hemophilia with mild bleeding phenotype : molecular characterization and global coagulation profile 120
State of the art of rare bleeding disorders database (RBDD) 120
Localization and Function of Platelet ADAMTS-13 118
Product type and other environmental risk factors for inhibitor development in severe hemophilia A 118
The P303T mutation in the human factor VII (FVII) gene alters the conformational state of the enzyme and causes a severe functional deficiency 116
Detection of maternal DNA in human cord blood stored for allotransplantation by a highly sensitive chemiluminescent method 116
A novel mutation of alpha2-plasmin inhibitor gene causes an inherited deficiency and a bleeding tendency 116
Pitfalls in molecular diagnosis in a family with severe factor VII (FVII) deficiency-misdiagnosis by direct sequence analysis using a PCR product 112
Prenatal diagnosis and preimplantation genetic diagnosis : novel technologies and state of the art of PGD in different regions of the world 109
Clustered F8 missense mutations cause hemophilia A by combined alteration of splicing and protein biosynthesis and activity 109
Molecular Aggregation of Marketed Recombinant FVIII Products: Biochemical Evidence and Functional Effects 104
Patients Informative Booklet on the Women with rare bleeding disorders project 100
Development of a specific monoclonal antibody to detect male cells expressing the rps4y1 protein 98
Residual plasmatic activity of ADAMTS13 correlates with phenotype severity in congenital thrombotic thrombocytopenic purpura 95
Future of coagulation factor replacement therapy 91
Gynecological and obstetrical manifestations of inherited bleeding disorders in women 90
Performance of a clinical risk prediction model for inhibitor formation in severe haemophilia A 83
Recurrent mutations identified on LMAN1 and coagulation factors VII, X, XIII genes 81
Long-term prophylaxis in severe factor VII deficiency 78
Management of pregnancy and delivery in women with inherited bleeding disorders 72
X Chromosome inactivation: a modifier of factor VIII and IX plasma levels and bleeding phenotype in Haemophilia carriers 72
Clinical advances in gene therapy updates on clinical trials of gene therapy in haemophilia 68
Treatment of hemophilia in the near future 65
Pregnancy complications and obstetric care in women with inherited bleeding disorders 63
Nonneutralizing antibodies against factor VIII and risk of inhibitor development in severe hemophilia A 60
Updates on Novel Non-Replacement Drugs for Hemophilia 57
The past and future of haemophilia : diagnosis, treatments, and its complications 52
Risk factors for inhibitor development in severe hemophilia A 50
Immune Responses to Plasma-Derived Versus Recombinant FVIII Products 48
Knowledge and attitudes toward gene therapy of a cohort of Italian patients with hemophilia 47
The EHA research roadmap: Blood coagulation and hemostatic disorders 47
Genetic variants at the chromosomal region 2q21.3 underlying inhibitor development in patients with severe haemophilia A 45
Degradation of two novel congenital TTP ADAMTS13 mutants by the cell proteasome prevents ADAMTS13 secretion 44
Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A : A SIPPET analysis 43
Advances in the treatment of bleeding disorders 42
Gender equity in hemophilia: need for healthcare, familial, and societal advocacy 27
Molecular study of vascular endothelial growth factor gene in Iranian patients after myocardial infarction 26
Exploring nonreplacement therapies’ impact on hemophilia and other rare bleeding disorders 25
Real-life experience in switching to new extended half-life products at European haemophilia centres 23
Post-authorization pharmacovigilance for hemophilia in Europe and the USA: Independence and transparency are keys 23
Fitusiran in haemophilia: a breakthrough drug with many unknowns 18
Recurrent mutations identified on LMAN1 and coagulation factors VII, X, XIII genes 6
null 3
Totale 9.868
Categoria #
all - tutte 26.308
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.308


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020597 0 0 0 0 0 0 0 58 203 194 78 64
2020/2021891 60 92 59 41 103 65 49 51 85 61 178 47
2021/20221.190 73 54 26 105 82 100 86 70 92 133 151 218
2022/20231.316 181 148 93 119 124 234 23 109 126 36 68 55
2023/2024706 35 73 37 39 138 71 29 27 22 46 71 118
2024/2025957 115 235 50 225 125 90 77 40 0 0 0 0
Totale 9.868